Phase

• Government agency
• Country: United States

NASA Glenn Invites Phase 1 Proposals for Aerospace Power Systems Laboratory

NASA’s Glenn Research Center in Cleveland is seeking Phase 1 proposals for the design and construction of the Aerospace Power Systems Laboratory. The principal purpose of this procurement is to deliver a laboratory facility to support the testing and development of power systems, with associated…

• Country: Cyprus

Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial

• Press releases
• Country: United States

Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value

First Patient Dosed with JOTROL ™ Marks Major Clinical Milestone for Jupiter Neurosciences’ Phase 2a Study Evaluating Safety, Pharmacokinetics and Biomarkers of JOTROL ™ in Patients with Parkinson’s Disease

• Press releases
• Country: United States

XRDNA Completes Phase I of Project OPAL, First Mission Field Test of Mission Fabric™

Operational Prototyping for Advanced Logistics initiative moves XRDNA's persistent identity, sensor fusion, and AI-assisted mission infrastructure into the field SALT LAKE CITY, Oct. 6, 2026 /PRNewswire/ -- XRDNA Inc., developer of persistent identity and mission-context infrastructure...

• Press releases
• Country: United States

Visual Edge IT Appoints Chief Growth Officer and Chief Revenue Officer to Support Next Phase of Growth

NORTH CANTON, Ohio, Oct. 6, 2026 /PRNewswire/ -- Visual Edge IT (VEIT), one of the nation's largest print and managed IT services organizations, today announced the promotions of Cameron Jones to Chief Growth Officer and Sara Grofcsik to Chief Revenue Officer. Together with recently...

• Press releases
• Country: United States

John C. Adams Announces his Debut Novel The Third Phase, a Timeless Wisdom Meets Revolutionary Vision in Epic Political Thriller

A sweeping journey from Olympic glory to global leadership explores justice, spirituality, democracy, and humanity's capacity for transformation NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Author John C. Adams announces the release of his debut novel, The Third Phase, an ambitious political...

• Press releases
• Country: United States

Cadara Announces Executive Leadership Appointments to Drive Next Phase of Growth and Innovation

Expanded leadership team brings deep healthcare technology and industry expertise to advance Cadara's vision for the future of post-acute revenue management NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Cadara™, formerly National Care Systems, today announced a series of executive leadership...

• Press releases
• Country: United States

SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

• SCY-770 was well tolerated with a favorable safety profile in healthy adult participants at higher doses than previously evaluated

• Press releases
• Country: United States

TranspireBio Announces Successful Completion of a Pivotal Phase 1 Study with its Proprietary Springboard™ Soft Mist Inhaler Platform

SUNRISE, Fla., Oct. 6, 2026 /PRNewswire/ -- TranspireBio Holdings Inc., an integrated U.S.-based clinical-stage, biopharmaceutical company advancing inhaled therapeutics for respiratory and systemic diseases, today announced the successful completion of a pivotal Phase 1 pharmacokinetic...

• Press releases
• Country: United States

OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain

LONDON and NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced first patients enrolled…